Latest filing published 04 Nov 2020 for Elevance Health, Inc., €1.2M.
All filings by Thomas C. Zielinski on record concern Elevance Health, Inc. Over a trading history stretching from 1 March 2016 to 3 November 2020, the count stands at 56 filings.
On the market, this insider has only sold: 18 sales, €25.3M in total. The rest of the record consists of 17 share grants and 21 option exercises. 2020 to date brings no purchases and 7 sales.
The latest filing, published on 4 November 2020, reports an open-market sale of €1.2M in Elevance Health, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 56 declarations